Board of Directors

Our esteemed board of directors provides strategic guidance to help us grow and achieve ongoing levels of excellence.

Michael Weintraub


Michael is Co-Founder and CEO of Humedica, acquired by UnitedHealth Group (UHG) in 2013. Michael has broadened his role to lead Optum Analytics within UHG’s healthcare technology – information – services business, Optum. Prior to launching Humedica, Michael served as Senior Managing Director at Leerink Partners, a leading health care investment bank. Previously, he was President and CEO of PHARMetrics, a health care informatics company, which was successfully sold to IMS Health in 2005. He serves as Founding Chairman of the Board of Phreesia, a software company that develops automated patient check-in tools. Michael is a member of the Board of Directors of JDRF New England Chapter; as well as The College Diabetes Network (CDN), whose mission is to empower and improve the lives of students living with Type 1 diabetes through peer support and access to information and resources. In 2010, Michael was selected to participate in 12x12, a Massachusetts initiative to multiply entrepreneurship by engaging the creativity and experience of 12 of the state’s leading CEO’s and 12 venture capitalists. Michael is a board member of the Massachusetts Competitive Partnership Digital Health Initiative, as well as the Innovation and Digital Health Accelerator for Boston Children’s Hospital. He serves as a mentor at the Harvard Innovation Lab (iLab), a unique collaboration and education space designed to foster entrepreneurship and innovation across Harvard. Michael is a past Board member of Anceta, the informatics subsidiary of the American Medical Group Association (AMGA), having served on the Board for seven years. Michael received his MBA from Harvard Business School and his bachelor’s degree in Economics from Brandeis University.

Chaim Indig


Chaim is a co-founder of Phreesia, a healthcare patient intake management solution started in 2005 to revolutionize the patient experience. Under his leadership, Phreesia has established a broad national footprint, developed strategic partnerships with some of the world's largest healthcare companies and earned accolades for its role in generating workplace efficiencies and improving clinical care. Chaim has become a trusted industry expert and speaker, and is recognized as a prominent business leader. In 2011, he was a finalist for Ernst & Young's "Entrepreneur of the Year" Award, and he has been featured in the Stanford Social Innovation Review as an innovator in the healthcare field. Prior to founding Phreesia, Chaim led the successful introduction of the high-end analytics software company, Spotfire, into the pharmaceutical marketing space. Chaim was also an integral member of the original team at OLAP@Work, the leader in SQL server front-end tools.

Ed Cahill


Edward L. Cahill is a partner of HLM Venture Partners. Previously, Ed was a founding partner of Cahill, Warnock & Company (now Camden Partners), a Baltimore-based venture capital firm, and a managing director of Alex. Brown & Sons, where he headed the firm's healthcare group from 1986 to 1995. During his leadership at Alex. Brown & Sons, the firm underwrote public offerings or provided merger advisory services for over 200 healthcare companies, including the first outpatient surgery, rehabilitation and managed care companies to go public, and several leading biopharmaceutical companies. Ed is a director at Masimo Corporation, and he previously served as a director at Prism Education Group, Animas Corporation, Centene Corporation (NYSE), Spinal Concepts, and Automated Healthcare and Gene Medicine (NASDAQ). He is a trustee of Johns Hopkins Medicine, the Johns Hopkins Hospital and Health System and Mercy Health Services.

Alan Spoon


Alan brings more than 20 years of operating, strategy and investment experience to Polaris Partners. He came to the firm from the Washington Post Company, where he worked for 18 years. During his career with the Washington Post Company, he served as president, board member, chief financial officer, president of Newsweek, head of newspaper marketing and head of corporate business development. The Washington Post Company has significant activities in newspapers, educational markets (Kaplan), television, cable and magazines. At the Washington Post Company, Alan also was responsible for early stage technology investments in cellular (Cellular One and digital PCS), distance learning and educational software and information and e-commerce services (including,, Junglee, BrassRing, and WebTV). Prior to the Washington Post Company, Alan was an officer at the Boston Consulting Group, an international management consulting firm specializing in corporate strategy.

Victor Kats


Victor Kats joined AHV from Allscripts-Misys, a $3 billion healthcare technology company where he led corporate development, strategic planning and other operating initiatives. Victor leads AHV's Healthcare Technology investments and brings more than 17 years of transaction and healthcare experience in the hospital, physician, revenue-cycle and home-health markets. He has an extensive background in mergers and acquisitions, strategy and operations. At Allscripts-Misys, he served as vice president of Corporate Development after fulfilling a similar role at Misys. Prior to Misys, Victor served as a vice president with Lehman Brothers, where he focused on the communications, media and technology sectors. He graduated from the University of North Carolina at Chapel Hill and received an MBA from the Wharton School of Business.

Bill Conroy


At Initiate Systems, Inc., an international leader in data management solutions, Bill Conroy served for eight years as the CEO, president and member of the board of directors, until he led the sale of the company to IBM in March 2010. During Conroy's tenure, Initiate's revenue grew 700%, with a compound annual growth rate of 50%, and in 2009, he was awarded the "CEO of the Year" award from the Illinois Technology Association in recognition of his achievements at the company. Conroy has held leadership positions at Click Commerce, Tenfold Corporation and Oracle Corporation, and sits on several boards, including Kareo, a medical office software and services company.

Scott Perricelli


With more than 15 years of private equity and investment banking experience, Scott Perricelli leads LLR Partners’ investments in healthcare and education services. Prior to joining LLR, Scott was a principal at Draper Triangle Ventures, an investor in high-technology startup companies in Ohio and Pennsylvania. He previously served as an associate at Advanta Partners. Earlier in his career, Scott worked in investment banking at William Blair & Co. and JP Morgan and Company. Scott's current investments include Phreesia, IOD Incorporated, Physicians Immediate Care, Regency Beauty Institute, Vector Learning and Vivere Health. He has previously invested in American Renal Associates, BrightHeart Veterinary Centers, CyberShift, EKR Therapeutics, excelleRx and Medmark. Scott earned a BS from Bucknell University and his MBA from Northwestern University.

Tom Hawes


Tom Hawes is a managing director of Sandbox Industries. He is the board chairman for Patientco, and serves on the board of directors of HeartFlow, InVivoLink, Phreesia, Wellspring Healthcare and Nexidia. Before joining Sandbox, Tom matched at Yale School of Medicine for residency and completed his first year of medical training at Greenwich Hospital. During his medical training, he worked on clinical studies at the ISK Institute for Orthopaedics and Sports Medicine and on outcomes research at the National Cancer Institute and NYMC’s Cardiothoracic Surgery Department. Tom is on the National Advisory Board of the Desmoid Tumor Research Foundation. He holds a BA from Brigham Young University, an MD from New York Medical College and an MBA from Harvard Business School. He is also a Kauffman Fellow.

Russ Ray


Russell T. Ray is a director at Prism Education Group. Prior to joining Prism, he was a director of Socios Mayores en Salud, Inc., until its sale to Triple S Corporation in 2012, and a Board Observer of CBR Systems before its sale to GTCR in 2012. Previously, Russ was a managing director and global co-head of Health Care Investment Banking at Credit Suisse First Boston, where he focused on providing strategic and financial advice to life sciences, healthcare services and medical device companies. He spent 12 years at Deutsche Bank and its predecessor entities, BT Alex. Brown and Alex. Brown & Sons, as a managing director and global head of healthcare investment banking. Russ began his career in investment banking in 1982 as a member of the High Technology and Emerging Growth Group at Merrill Lynch. During his investment banking career, Russ successfully completed over 175 merger and financing transactions for leading healthcare companies in the United States, Europe and Israel. Russ is a director of Allergan, Inc. (NYSE) and Phreesia and a Board Observer at CBR Systems, Prism Education Group and Socios Mayores en Salud.

2016 © Phreesia™